TSO3, an innovator in sterilization technology for medical devices in healthcare settings, has entered into a strategic partner facility agreement with Mount Sinai hospital of New York.
Under the terms of the agreement, Mount Sinai Hospital and TSO3 have agreed to deploy TSO3‘s Sterizone VP4 Sterilizer technology and collaboratively share and evaluate related in-use technical and device reprocessing data.
“We are privileged to work closely with Mount Sinai as we continue the global deployment of our Sterizone VP4 Sterilizers,” said Ric Rumble, TSO3‘s president and CEO. “We aim to further validate with Mount Sinai and other leading hospitals our ability to significantly improve existing sterilization processes, increase throughput and reduce cost, while exploring and assessing the process to enable routine terminal sterilization of multi-channel flexible endoscopes.”
TSO3
tso3.com
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]
